{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T11:05:58Z","timestamp":1783681558763,"version":"3.55.0"},"reference-count":49,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,7]]},"abstract":"<jats:p>Cell-free DNA is an advancing technology with increasing applications in screening, diagnosis, and treatment for several disease processes. The shared physiologic, genetic, and epigenetic characteristics of placental physiology and tumor development have become apparent to both clinicians and researchers. Maternal malignancy has been reported as a cause of false-positive prenatal cell-free DNA screening results. The detection of multiple aneuploidies or a single autosomal monosomy increases the chance for an underlying maternal malignancy when the result is discordant with fetal diagnostic testing. There is currently no consensus guideline on counseling and evaluation of patients with concern for malignancy from cell-free DNA testing. Furthermore, laboratories differ significantly in reporting policies, terminology, and in reporting strategies and methods used for unexpected or incidental findings. The ordering practitioner is therefore tasked to understand the policies of their laboratory of choice to provide adequate pretest and posttest genetic counseling. In pretest counseling, the potential for incidental or unexpected findings or nonreportable results should be explained. With an abnormal, unanticipated, or nonreportable result, posttest counseling should include a description of possible fetal or maternal diagnoses, including malignancy. Health care professionals should explain options for further evaluation and management, including a recommendation for fetal diagnostic testing. The medical workup recommended by various authors to evaluate cancer risk is based on consensus, experience, and expert opinion. These strategies should incorporate the patient's desire for information, cost, and family and personal medical history. Ongoing research and multi-disciplinary collaboration in this area is critical to identify best practices in management of complex results from this increasingly common screening test.<\/jats:p>","DOI":"10.1097\/aog.0000000000004833","type":"journal-article","created":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T22:01:07Z","timestamp":1655157667000},"page":"121-131","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":19,"title":["Incidental Detection of Maternal Malignancy by Fetal Cell-Free DNA Screening"],"prefix":"10.1097","volume":"140","author":[{"given":"Britton D.","family":"Rink","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blair K.","family":"Stevens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary E.","family":"Norton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,6,7]]},"reference":[{"key":"R1-20250423","first-page":"241","article-title":"Nuclear acids in human blood plasma","volume":"142","author":"Mandel","year":"1948","journal-title":"C R Seances Soc Biol Fil"},{"key":"R2-20250423","first-page":"646","article-title":"Free DNA in the serum of cancer patients and the effect of therapy","volume":"37","author":"Leon","year":"1977","journal-title":"Cancer Res"},{"key":"R3-20250423","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0140-6736(97)02174-0","article-title":"Presence of fetal DNA in maternal plasma and serum","volume":"350","author":"Lo","year":"1997","journal-title":"Lancet"},{"key":"R4-20250423","doi-asserted-by":"crossref","first-page":"137.e1","DOI":"10.1016\/j.ajog.2012.05.021","article-title":"Non-Invasive Chromosomal Evaluation (NICE) Study: results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18","volume":"207","author":"Norton","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"R5-20250423","doi-asserted-by":"crossref","first-page":"319.e1","DOI":"10.1016\/j.ajog.2012.01.030","article-title":"Noninvasive prenatal detection and selective analysis of cell-free DNA obtained from maternal blood: evaluation for trisomy 21 and trisomy 18","volume":"206","author":"Sparks","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"R6-20250423","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1097\/GIM.0b013e3182368a0e","article-title":"DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study","volume":"13","author":"Palomaki","year":"2011","journal-title":"Genet Med"},{"key":"R7-20250423","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/pd.5620","article-title":"Fetal fraction and noninvasive prenatal testing: what clinicians need to know","volume":"40","author":"Hui","year":"2020","journal-title":"Prenat Diagn"},{"key":"R8-20250423","doi-asserted-by":"crossref","first-page":"8583","DOI":"10.1073\/pnas.1406103111","article-title":"Size-based molecular diagnostics using plasma DNA for non-invasive prenatal testing","volume":"111","author":"Yu","year":"2014","journal-title":"Proc Natl Acad Sci"},{"key":"R9-20250423","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1373\/clinchem.2003.024893","article-title":"Size distributions of maternal and fetal DNA in maternal plasma","volume":"50","author":"Chan","year":"2004","journal-title":"Clin Chem"},{"key":"R10-20250423","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1086\/302205","article-title":"Rapid clearance of fetal DNA from maternal plasma","volume":"64","author":"Lo","year":"1999","journal-title":"Am J Hum Genet"},{"key":"R11-20250423","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/uog.17484","article-title":"Analysis of cell-free DNA in maternal blood in screening for aneuploidies: updated meta-analysis","volume":"50","author":"Gil","year":"2017","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R12-20250423","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/uog.23763","article-title":"Influence of fibroids on cell-free DNA screening accuracy","volume":"59","author":"Scott","year":"2022","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R13-20250423","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1038\/gim.2017.219","article-title":"Cherchez la femme: maternal incidental findings can explain discordant prenatal cell-free DNA sequencing results","volume":"20","author":"Bianchi","year":"2017","journal-title":"Genet Med"},{"key":"R14-20250423","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1001\/jama.2015.7120","article-title":"Noninvasive prenatal testing and incidental detection of occult maternal malignancies","volume":"314","author":"Bianchi","year":"2015","journal-title":"JAMA"},{"key":"R15-20250423","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.molonc.2014.12.003","article-title":"Circulating tumor DNA as a non-invasive substitute to metastasis biopsy for tumor genotyping and personalized medicine in a prospective trial across all tumor types","volume":"9","author":"Lebofsky","year":"2015","journal-title":"Mol Oncol"},{"key":"R16-20250423","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/nature08822","article-title":"The landscape of somatic copy-number alteration across human cancers","volume":"463","author":"Beroukhim","year":"2010","journal-title":"Nature"},{"key":"R17-20250423","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/s41586-020-1969-6","article-title":"Pan-cancer analysis of whole genomes","volume":"578","year":"2020","journal-title":"Nature"},{"key":"R18-20250423","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4132\/jptm.2017.05.21","article-title":"Extracellular vesicles and the promise of continuous liquid biopsies","volume":"52","author":"Armstrong","year":"2018","journal-title":"J Pathol Transl Med"},{"key":"R19-20250423","first-page":"1659","article-title":"DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells","volume":"61","author":"Jahr","year":"2001","journal-title":"Cancer Res"},{"key":"R20-20250423","doi-asserted-by":"crossref","first-page":"e1006162","DOI":"10.1371\/journal.pgen.1006162","article-title":"Fragment length of circulating tumor DNA","volume":"12","author":"Underhill","year":"2016","journal-title":"PLoS Genet"},{"key":"R21-20250423","doi-asserted-by":"crossref","first-page":"5403","DOI":"10.3390\/cancers13215403","article-title":"Monitoring cfDNA in plasma and in other liquid biopsies of advanced EGFR mutated NSCLC patients: a pilot study and a review of the literature","volume":"13","author":"Verz\u00e8","year":"2021","journal-title":"Cancers (Basel)"},{"key":"R22-20250423","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3390\/genes12030349","article-title":"Liquid biopsies: applications for cancer diagnosis and monitoring","volume":"12","author":"Martins","year":"2021","journal-title":"Genes (Basel)"},{"key":"R23-20250423","doi-asserted-by":"crossref","first-page":"71013","DOI":"10.18632\/oncotarget.11717","article-title":"Cell-free DNA and next-generation sequencing in the service of personalized medicine for lung cancer","volume":"7","author":"Bennett","year":"2016","journal-title":"Oncotarget"},{"key":"R24-20250423","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s40246-019-0220-8","article-title":"Next-generation sequencing in liquid biopsy: cancer screening and early detection","volume":"13","author":"Chen","year":"2019","journal-title":"Hum Genomics"},{"key":"R25-20250423","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature12065","article-title":"Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA","volume":"497","author":"Murtaza","year":"2013","journal-title":"Nature"},{"key":"R26-20250423","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/s41571-020-00457-x","article-title":"Liquid biopsy enters the clinic - implementation issues and future challenges","volume":"18","author":"Ignatiadis","year":"2021","journal-title":"Nat Rev Clin Oncol"},{"key":"R27-20250423","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1093\/annonc\/mdy476","article-title":"Genomewide copy number alteration screening of circulating plasma DNA: potential for the detection of incipient tumors","volume":"30","author":"Lenaerts","year":"2019","journal-title":"Ann Oncol"},{"key":"R28-20250423","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/ng.2271","article-title":"Detectable clonal mosaicism from birth to old age and its relationship to cancer","volume":"44","author":"Laurie","year":"2012","journal-title":"Nat Genet"},{"key":"R29-20250423","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1067\/mob.2001.114867","article-title":"Obstetrical deliveries associated with maternal malignancy in California, 1992 through 1997","volume":"184","author":"Smith","year":"2001","journal-title":"Am J Obstet Gynecol"},{"key":"R30-20250423","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/pd.4100","article-title":"Discordant noninvasive prenatal testing results in a patient subsequently diagnosed with metastatic disease","volume":"33","author":"Osborne","year":"2013","journal-title":"Prenat Diagn"},{"key":"R31-20250423","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/pd.4778","article-title":"Follow-up of multiple aneuploidies and single monosomies detected by noninvasive prenatal testing: implications for management and counseling","volume":"36","author":"Snyder","year":"2016","journal-title":"Prenat Diagn"},{"key":"R32-20250423","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1373\/clinchem.2017.277517","article-title":"Incidental detection of maternal neoplasia in noninvasive prenatal testing","volume":"64","author":"Dharajiya","year":"2018","journal-title":"Clin Chem"},{"key":"R33-20250423","first-page":"814","article-title":"Presymptomatic identification of cancers in pregnant women during noninvasive prenatal testing","volume":"1","author":"Amant","year":"2015","journal-title":"JAMA"},{"key":"R34-20250423","doi-asserted-by":"crossref","first-page":"16266","DOI":"10.1073\/pnas.0808319105","article-title":"Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood","volume":"105","author":"Fan","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R35-20250423","doi-asserted-by":"crossref","first-page":"20458","DOI":"10.1073\/pnas.0810641105","article-title":"Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma","volume":"105","author":"Chiu","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R36-20250423","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/pd.4103","article-title":"Validation of targeted sequencing of single-nucleotide polymorphisms for non-invasive prenatal detection of aneuploidy of chromosomes 13, 18, 21, X, and Y","volume":"33","author":"Nicolaides","year":"2013","journal-title":"Prenat Diagn"},{"key":"R37-20250423","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1159\/000367626","article-title":"Microarray-based cell-free DNA analysis improves noninvasive prenatal testing","volume":"36","author":"Juneau","year":"2014","journal-title":"Fetal Diagn Ther"},{"key":"R38-20250423","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1097\/AOG.0000000000004084","article-title":"Screening for fetal chromosomal abnormalities. ACOG Practice Bulletin No. 226. American College of Obstetricians and Gynecologists","volume":"136","year":"2020","journal-title":"Obstet Gynecol"},{"key":"R39-20250423","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/gim.2016.97","article-title":"Noninvasive prenatal screening for fetal aneuploidy, 2016 update: a position statement of the American College of Medical Genetics and Genomics","volume":"18","author":"Gregg","year":"2016","journal-title":"Genet Med"},{"key":"R40-20250423","doi-asserted-by":"crossref","first-page":"e96","DOI":"10.1097\/AOG.0000000000002020","article-title":"Counseling about genetic testing and communication of genetic test results. Committee Opinion No. 693. American College of Obstetricians and Gynecologists","volume":"129","year":"2017","journal-title":"Obstet Gynecol"},{"key":"R41-20250423","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1002\/pd.5544","article-title":"Pregnant women with confirmed neoplasms should not have noninvasive prenatal testing","volume":"39","author":"Lenaerts","year":"2019","journal-title":"Prenat Diagn"},{"key":"R42-20250423","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/pd.5260","article-title":"Biological explanations for discordant noninvasive prenatal test results: preliminary data and lessons learned","volume":"38","author":"Wilkins-Haug","year":"2018","journal-title":"Prenat Diagn"},{"key":"R43-20250423","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/AOG.0000000000000637","article-title":"Fetal sex chromosome testing by maternal plasma DNA sequencing: clinical laboratory experience and biology","volume":"125","author":"Bianchi","year":"2015","journal-title":"Obstet Gynecol"},{"key":"R44-20250423","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1097\/AOG.0000000000002474","article-title":"Maternal malignancy evaluation after discordant cell-free DNA results","volume":"131","author":"Carlson","year":"2018","journal-title":"Obstet Gynecol"},{"key":"R45-20250423","doi-asserted-by":"crossref","first-page":"28","DOI":"10.14740\/wjon1177","article-title":"Cancer during pregnancy: the oncologist overview","volume":"10","author":"Hepner","year":"2019","journal-title":"World J Oncol"},{"key":"R46-20250423","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1634\/theoncologist.2002-0279","article-title":"Coexistence of pregnancy and malignancy","volume":"7","author":"Pavlidis","year":"2002","journal-title":"Oncologist"},{"key":"R47-20250423","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1373\/clinchem.2019.306548","article-title":"Noninvasive prenatal testing and detection of occult maternal malignancies","volume":"65","author":"Lenaerts","year":"2019","journal-title":"Clin Chem"},{"key":"R48-20250423","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1007\/s00330-017-5126-z","article-title":"Feasibility of whole-body diffusion-weighted MRI for detection of primary tumour, nodal and distant metastases in women with cancer during pregnancy: a pilot study","volume":"28","author":"Han","year":"2018","journal-title":"Eur Radiol"},{"key":"R49-20250423","doi-asserted-by":"crossref","first-page":"100856","DOI":"10.1016\/j.eclinm.2021.100856","article-title":"Comprehensive genome-wide analysis of routine non-invasive test data allows cancer prediction: a single-center retrospective analysis of over 85,000 pregnancies","volume":"35","author":"Lenaerts","year":"2021","journal-title":"EClinicalMedicine"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/AOG.0000000000004833","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T18:00:36Z","timestamp":1745431236000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/AOG.0000000000004833"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,7]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000004833","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6,7]]},"assertion":[{"value":"2021-11-16","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-03-03","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}